bims-p53actp53 mutations and anti-cancer therapy response
This report is maintained by Toni Martínez Bernabé, Universitat de les Illes Balears. It brings out roughly 4 papers per issue.
0000‒00‒00
 Sign up
2025–12–28
2025–12–21
0000‒00‒00
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
2025–12–14
2025–12–07
2025–11–30
2025–11–23
2025–11–16
2025–11–09
2025–11–02
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-midomi“MDM2 and mitochondria”, ∼ 4 p.p.i. ∼ 4 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-tremyl“Therapy resistance biology in myeloid leukemia”, ∼ 31 p.p.i. ∼ 31 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-scepro“Stem cell proteostasis”, ∼ 18 p.p.i. ∼ 18 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-ribost“Ribostasis and translation stress”, ∼ 48 p.p.i. ∼ 48 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-meract“Metabolic reprogramming and anti-cancer therapy”, ∼ 14 p.p.i. ∼ 14 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-tumhet“Tumor heterogeneity”, ∼ 8 p.p.i. ∼ 8 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-instec“Intestinal stem cells and chemoresistance in colon cancer and intestinal regeneration”, ∼ 13 p.p.i. ∼ 13 papers per issue
This page is being maintained by Thomas Krichel. It was last updated on 2026‒01‒26 at 14:45.